Hexagon Capital Partners’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-328
Closed -$5.95K 871
2025
Q1
$5.95K Sell
328
-223
-40% -$4K ﹤0.01% 1123
2024
Q4
$9.56K Buy
551
+525
+2,019% +$10.1K ﹤0.01% 1023
2024
Q3
$502 Buy
+26
New +$479 ﹤0.01% 1414

Other funds holding INVA

Hexagon Capital Partners's INVA Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Innoviva (INVA) in Q2 2025, closing a stake of 328 shares — an estimated $5.95K sold.

Hexagon Capital Partners first reported a position in INVA in Q3 2024 and held it in 3 quarters. The position peaked at $9.56K in Q4 2024. 266 funds tracked by Wall St. Rank hold INVA as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Innoviva position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 328 Innoviva shares in Q2 2025, an estimated $5.95K.
  • Hexagon Capital Partners first reported a position in Innoviva in Q3 2024 and held it in 3 quarters.
  • Hexagon Capital Partners's Innoviva position peaked at $9.56K in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Innoviva as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.